English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

biologic therapy in patients with inflammatory bowel disease: Results of a retrospective cohort analysis of 1,149 patients treated in Germany A Groth1, T Wilke2, A Brandes3, B Ratsch3, A Fuchs4, B Deiters5 , B Bokemeyer6 1IPAM e.V., Wismar, Germany, 2Ingress-Health HWM GmbH, Wismar, Germany, 3Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany, 4AOK PLUS, Dresden, Germany, 5GWQ ServicePlus AG, Düsseldorf, Germany, 6Gastroenterologische Gemeinschaftspraxis Minden, Germany

journal of crohn's and colitis

P635 Real-world treatment persistence and associated costs with biologic therapy in patients with inflammatory bowel disease (IBD): Results of a retrospective cohort analysis of 1,149 patients treated in Germany